• SARS-CoV-2 N Protein Disrupts GADD34 Immunity

  2026-09-16

  This Molecules study identifies an atypical stress-granule mechanism by which SARS-CoV-2 nucleocapsid protein sequesters GADD34 mRNA in N+/G3BP1+ foci. The resulting loss of GADD34 impairs IRF3 nuclear localization and interferon production, providing a mechanistic explanation for viral suppression of innate immunity.

• CFTRinh-172: From Channel Blockade to Translation

  2026-09-16

  CFTRinh-172 offers a precise way to separate CFTR channel activity from trafficking and upstream signaling. This thought-leadership perspective connects mechanistic epithelial biology with assay design, cystic fibrosis research, and translational models of secretory disease.

• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-09-15

  Liu et al. describe carrier-platin, a platinum-based nanotherapeutic designed to generate a rapid intracellular reactive oxygen species burst rather than relying on conventional DNA damage. The study links this mechanism to unusually fast cancer-cell killing, activity in multidrug-resistant models, and a distinct cell-death phenotype that is neither classical apoptosis nor ferroptosis.

• U-73122 Workflow for PLC Signaling and Invasion

  2026-09-15

  U-73122 enables acute phospholipase C inhibition across calcium-flux, chemotaxis, inflammation, and cancer-invasion workflows. This guide pairs practical dosing and handling recommendations with pathway controls that help distinguish PLC-dependent effects from nonspecific loss of cell function.

• Sodium dicloxacillin monohydrate for MSSA research

  2026-09-14

  Build more informative MSSA experiments by pairing extracellular and intracellular efficacy measurements with controlled pH and concentration windows. This workflow also adapts a selective spectrophotometric strategy for practical formulation checks while clearly separating validated evidence from assay-development recommendations.

• Asymmetric Cu Nanozyme for AMI Immune Homeostasis

  2026-09-14

  This study develops a bromine-doped, asymmetrically coordinated copper single-atom nanozyme that improves reactive oxygen species scavenging through electronic-structure engineering. In an acute myocardial infarction model, the material links redox control with cardiomyocyte protection, macrophage phenotype regulation, regulatory T-cell activity, and reduced fibrotic remodeling.

• Plk1 Control of p31comet in Checkpoint Exit

  2026-09-13

  The reference study identifies Polo-like kinase 1 (Plk1) as a negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. By showing that Plk1 phosphorylates p31comet at S102 and suppresses its cooperation with TRIP13, the work explains how cells may prevent premature checkpoint inactivation during mitosis.

• Click-Compatible BmTyr Proximity Labeling in T Cells

  2026-09-12

  The reference study develops a copper-dependent BmTyr platform that labels proximal proteins with an alkyne-phenol probe, avoiding biotin as the primary proximity-labeling handle. In primary T cells, the approach supports fluorescence imaging, affinity-based proteomics, and antibody-independent validation while revealing chromatin-associated localization of NKAP and confirming TNFα pathway components.

• JNJ-10198409: PDGF Receptor Inhibitor Workflows

  2026-09-12

  JNJ-10198409 enables dose-resolved studies of PDGF-BB receptor signaling, proliferation, migration, and angiogenic phenotypes. This practical workflow connects nanomolar biochemical benchmarking with time-resolved pathway controls and troubleshooting for vascular, oncology, and fibrotic disorder research.

• Annexin V-PE Apoptosis Detection Kit Workflow

  2026-09-11

  Build a rapid apoptosis detection workflow around phosphatidylserine externalization, with practical guidance for flow cytometry and live-cell microscopy. The approach is especially useful for connecting GANT61 response kinetics with pathway-level evidence in ALK-positive lymphoma models.

• Gramine and Ferroptosis in TNBC Research

  2026-09-11

  Gramine, also known as 1-(1H-indol-3-yl)-N,N-dimethylmethanamine, is a research compound linked to ferroptosis in triple-negative breast cancer models. A 2026 study associated its activity with CUL3–MTDH regulation, while product data define its formulation, solubility, purity, and storage requirements.

• Measuring Drug Response Beyond Relative Viability

  2026-09-10

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability to clarify how anticancer drugs affect proliferation and cell death. Its central implication is practical: drug-response studies should separate these biological outcomes and resolve their timing rather than treating a single viability signal as a complete measure of cytotoxicity.

• Axitinib: Separating Pathway Blockade From Cell Death

  2026-09-10

  Axitinib (AG 013736) is a powerful tool for studying VEGF signaling, but its biological effects require more than a single viability endpoint. This article presents a measurement-centered framework that distinguishes pathway inhibition, proliferative arrest, and genuine cell killing in cancer biology research.

• Angiotensin II: A Framework for Injury Models

  2026-09-09

  Angiotensin II is more than a vasopressor stimulus: it is a controllable perturbation for separating blood-pressure effects from vascular and renal injury. This article interprets a 2025 murine study and translates its endpoint strategy into stronger cardiovascular remodeling assays.

• Intraperitoneal CAR Macrophage Programming by mRNA-LNP

  2026-09-09

  Gu and colleagues developed a macrophage-targeted mRNA lipid nanoparticle platform for programming CAR macrophages directly in the peritoneal cavity and compared 36 CAR intracellular-domain designs. The lead CD3ζ–TLR4 configuration promoted inflammatory macrophage activity, remodeled the tumor microenvironment, expanded TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and improved the rationale for combining CAR-M therapy with PD-1/PD-L1 blockade.

7972 records 1/532 page Next 12345 下5页 Last page